- Home
- RARE vs SEE Comparison
RARE vs SEE Comparison
Compare RARE & SEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RARE
- SEE
- Stock Information
- Founded
- RARE 2010
- SEE 1960
- Country
- RARE United States
- SEE United States
- Employees
- RARE N/A
- SEE N/A
- Industry
- RARE Biotechnology: Pharmaceutical Preparations
- SEE Major Chemicals
- Sector
- RARE Health Care
- SEE Industrials
- Exchange
- RARE Nasdaq
- SEE Nasdaq
- Market Cap
- RARE 5.2B
- SEE 5.1B
- IPO Year
- RARE 2014
- SEE N/A
- Fundamental
- Price
- RARE $46.51
- SEE $35.28
- Analyst Decision
- RARE Strong Buy
- SEE Buy
- Analyst Count
- RARE 14
- SEE 12
- Target Price
- RARE $86.79
- SEE $41.00
- AVG Volume (30 Days)
- RARE 947.6K
- SEE 1.3M
- Earning Date
- RARE 11-05-2024
- SEE 11-07-2024
- Dividend Yield
- RARE N/A
- SEE 2.28%
- EPS Growth
- RARE N/A
- SEE 26.45
- EPS
- RARE N/A
- SEE 2.72
- Revenue
- RARE $522,745,000.00
- SEE $5,397,300,000.00
- Revenue This Year
- RARE $27.29
- SEE N/A
- Revenue Next Year
- RARE $18.30
- SEE $1.05
- P/E Ratio
- RARE N/A
- SEE $12.91
- Revenue Growth
- RARE 27.44
- SEE N/A
- 52 Week Low
- RARE $37.02
- SEE $30.87
- 52 Week High
- RARE $60.37
- SEE $41.14
- Technical
- Relative Strength Index (RSI)
- RARE 36.73
- SEE 42.68
- Support Level
- RARE $43.04
- SEE $34.42
- Resistance Level
- RARE $46.98
- SEE $35.33
- Average True Range (ATR)
- RARE 2.11
- SEE 1.00
- MACD
- RARE -0.31
- SEE -0.17
- Stochastic Oscillator
- RARE 34.47
- SEE 9.71
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About SEE Sealed Air Corporation
Sealed Air is organized via two reporting segments. Food care includes food packaging products like Cryovac, Darfresh, and OptiDure aimed primarily at meats. Product care includes Sealed Air's Bubble Wrap, Instapak, Jiffy mailers, and shrink film packaging systems that cater to industrial and e-commerce applications.